InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Denali Therapeutics Inc.

DNLI Clue Score33
United States Fiscal year ends December CIK 0001714899 Results filed 3 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

10
Insider
Date
Role
Action
Shares
Price
Amount
Carole Ho
5 Aug 2025
Chief Medical Officer
Exercised, kept
44,655
$0.68
$30.37K
Alexander O. Schuth
27 Dec 2024
COFO and Secretary
Exercised, kept
6,708
$5.28
$35.42K
Carole Ho
25 Nov 2024
Chief Medical Officer
Exercised, kept
17,845
$0.68
$12.13K
Alexander O. Schuth
22 Nov 2024
COFO and Secretary
Exercised, kept
20,516
$0.68
$13.95K
Alexander O. Schuth
8 Feb 2024
COFO and Secretary
Exercised, kept
50,000
$0.68
$34.00K
Alexander O. Schuth
7 Oct 2022
COFO and Secretary
Exercised, kept indirect
20,000
$0.68
$13.60K
Steve E. Krognes
19 Jul 2022
Director
Exercised, kept
62,500
$0.68
$42.50K
Ryan J. Watts
10 Feb 2022
President and CEO
Exercised, kept
6,118
$9.60
$58.73K
Ryan J. Watts
10 Feb 2022
President and CEO
Exercised, kept
64,631
$5.28
$341.25K
Alexander O. Schuth
20 Sep 2021
COO and Secretary
Exercised, kept
9,045
$0.68
$6.15K
Showing 250 of 516 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 397
Amendments (4/A) skipped 11
Filings about a different issuer 0
Unreadable filings 0
Joint filings 16
Sales on a Rule 10b5-1 plan 46
Sales straight out of an exercise 68
Sales at will 387
Transactions with no price 0
Shares from compensation/vesting 63,608,485
Sales filed before the plan box existed 354
History held since 8 Dec 2017